REducing 30-day ADMIssions in posT-discharge Subjects (READMIT) (READMIT-HF)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01574144
Recruitment Status : Completed
First Posted : April 10, 2012
Last Update Posted : July 24, 2013
Information provided by (Responsible Party):
Medtronic Cardiac Rhythm and Heart Failure

Brief Summary:

The purpose of this observational study is to collect and characterize multiple physiologic data from a broad subset of subjects with acute heart failure (HF)

Changes in physiologic data are expected to correlate with 30-day readmission rates in this population

Condition or disease Intervention/treatment
Acute Decompensated Heart Failure Device: AVIVO™ PiiX Patch Monitor System

Detailed Description:

This is a multi-center, non-randomized feasibility study aimed at obtaining data from systolic and diastolic HF subjects in the hospital, with continued monitoring using an external wearable monitor for up to 4 weeks post-hospital-discharge. Data will be collected during the hospital stay and at in office follow-up visits at 1 week and 1 month post-hospital discharge

The data will help generate hypotheses and aid in determining whether development of a detection algorithm for acute heart failure decompensation is feasible. Due to the feasibility nature of this study there is no minimum required sample size but it is anticipated that the study will enroll up to 100 subjects from seven (7) study sites in the United States and one (1) study site in Australia

The study objectives are:

  • Collect and characterize physiologic data from subjects with acute decompensated heart failure.
  • Characterization of data related to health care utilizations within 30-days Post-discharge
  • Correlation between patch monitor collected data and inpatient clinical data
  • Correlation between patch monitor data and other clinical data collected after patient discharge (30-60 days)

Study Type : Observational
Actual Enrollment : 70 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Observational Study of Reducing 30-day Admissions in Post-discharge Subjects
Study Start Date : March 2012
Actual Primary Completion Date : April 2013
Actual Study Completion Date : July 2013

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Heart Failure

Group/Cohort Intervention/treatment
AVIVO™ PiiX Patch Monitor System
Heart failure patients monitored continuously for 30 days post-discharge.
Device: AVIVO™ PiiX Patch Monitor System
External monitoring for 30 days post-discharge.

Primary Outcome Measures :
  1. Number of health care utilizations 30 days post-discharge [ Time Frame: 30 days post-discharge ]

Secondary Outcome Measures :
  1. Change in impedance 30 days post-discharge [ Time Frame: 30 days post-discharge ]
    Measures change in weight and tissue impedance throughout the monitoring period post-discharge

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Heart failure patients who are admitted to the hospital.

Inclusion Criteria:

  • Subject with acute decompensated heart failure
  • Subject (or legal guardian) willing to give consent for their participation
  • Subject ≥18 years of age

Exclusion Criteria:

  • Subject who is expected to receive a heart transplant or a ventricular assist device within 6 months
  • Subject who cannot tolerate placement of external patch monitor on chest in the proposed location (ECG Lead II orientation)
  • Subject with known allergies or hypersensitivities to adhesives or hydrogels
  • Subject with implantable devices with active minute ventilation sensors.
  • Subject who will not comply to study protocol requirements. This includes completing required data collection, and attending required follow up study visits.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT01574144

United States, California
Scripps Green Hospital
LaJolla, California, United States, 92037
United States, Florida
Bay Area Cardiology
Tampa, Florida, United States, 33511-5908
United States, Minnesota
United Heart and Cardiovascular
St. Paul, Minnesota, United States, 55102-2568
United States, New Jersey
Morristown Memorial Hospital
Morristown, New Jersey, United States, 07962
United States, New York
Mohawk Valley Heart Institute
Utica, New York, United States, 13501-5930
United States, Ohio
University of Cincinnati
Cincinnati, Ohio, United States, 45219-2364
United States, Tennessee
Vanderbilt University
Nashville, Tennessee, United States, 37232
Australia, Victoria
The Alfred Hospital
Melbourne, Victoria, Australia, 3004
Sponsors and Collaborators
Medtronic Cardiac Rhythm and Heart Failure
Study Director: READMIT-HF Study Team Medtronic

Responsible Party: Medtronic Cardiac Rhythm and Heart Failure Identifier: NCT01574144     History of Changes
Other Study ID Numbers: READMIT-HF
First Posted: April 10, 2012    Key Record Dates
Last Update Posted: July 24, 2013
Last Verified: July 2013

Keywords provided by Medtronic Cardiac Rhythm and Heart Failure:
Heart Failure

Additional relevant MeSH terms:
Heart Failure
Heart Diseases
Cardiovascular Diseases